Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias.

Francisco J MedaJoel SimrénBarbara BorroniValentina CantoniSilvana ArchettiGiorgio BiasiottoUlf AndreassonKaj BlennowHlin KvartsbergHenrik Zetterberg

Published in: Clinical chemistry and laboratory medicine (2023)

mutation carriers, which may guide further evaluation of the patient. This assay might also be used to evaluate the effect of novel PGRN-targeting drugs and therapies.

Keyphrases

case report
high throughput
cancer therapy
liquid chromatography
drug delivery